Retinoic acid responsiveness of cells and tissues in developing fetal limbs evaluated in a RAREhsplacZ transgenic mouse model

Journal of Orthopaedic Research

Volumn 16, Issue 3, 1998, Pages 355-364

  Von Schroeder, H P ^a   Heersche, J N M ^a  

^a Kleinert Institute   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BONE; CARTILAGE; CELLS; FETAL MONITORING; MATHEMATICAL MODELS; MUSCULOSKELETAL SYSTEM; TISSUE; VITAMINS;

FETAL LIMBS; FETAL MALFORMATIONS; LIMB DEVELOPMENT; MORPHOGENESIS; RETINOIC ACID; TRANSGENIC MOUSE MODEL;

GROWTH KINETICS;

RETINOIC ACID RECEPTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; FETUS; FETUS DEVELOPMENT; FETUS MALFORMATION; HORMONE RESPONSIVE ELEMENT; LIMB DEVELOPMENT; MOUSE; MYOBLAST; NONHUMAN; OSTEOBLAST; OSTEOCLAST; PRIORITY JOURNAL; TRANSGENIC MOUSE;

EID: 0032077714     PISSN: 07360266     EISSN: None     Source Type: Journal    
DOI: 10.1002/jor.1100160312     Document Type: Article

References (69)

1. 1 Albagli‐Curiel O, Carnac G, Vandromme M, Vincent S, Crépieux P, Bonnieu A: Serum‐induced inhibition of myogenesis is differentially relieved by retinoic acid and triiodothyronine in C2 murine muscle cells. Differentiation 52: 201–210, 1993
2. 2 Balkan W, Colbert M, Bock C, Linney E: Transgenic indicator mice for studying activated retinoic acid receptors during development. Proc Natl Acad Sci U S A 89: 3347–3351, 1992
3. 3 Barnicot NA: Local action of calciferol and vitamin A on bone. Nature 162: 848–849, 1948
4. 4 Busam KJ, Geiser AG, Roberts AB, Sporn MB: Synergistic increase of phorbol ester‐induced c‐fos mRNA expression by retinoic acid through stabilization of the c‐fos message. Oncogene 8: 2267–2273, 1993
5. 5 Chen YP, Solursh M: The determination of myogenic and cartilage cells in the early chick embryo and the modifying effect of retinoic acid. Roux's Arch Devel Biol 200: 162–171, 1991
6. 6 Chuong CM, Ting SA, Widelitz RB, Lee Y‐S: Mechanism of skin morphogenesis. II. Retinoic acid modulates axis orientation and phenotype of skin appendages. Development 115: 839–852, 1992
7. 7 Dietz U, Aigner T, Bertling WM, von der Mark K: Alterations of collagen mRNA expression during retinoic acid induced chondrocyte modulation: absence of untranslated α1(I) mRNA in hyaline chondrocytes. J Cell Biochem 52: 57–68, 1993
8. 8 Dollé P, Ruberte E, Kastner P, Petkovich M, Stoner CM, Gudas LJ, Chambon P: Differential expression of genes encoding α, β, and γ retinoic acid receptors and CRABP in the developing limbs of the mouse. Nature 342: 702–705, 1989
9. 9 Dollé P, Fraulob V, Kastner P, Chambon P: Developmental expression of murine retinoid X receptor (RXR) genes. Mech Dev 45: 91–104, 1994
10. 10 Duboule D: How to make a limb? Science 266: 575–576, 1994
11. 11 Ellis CN, Madison KC, Pennes DR, Martel W, Voorhees JJ: Isotretinoin therapy is associated with early skeletal radiographic changes. J Am Acad Dermatol 10: 1024–1029, 1984
12. 12 Ferguson MW: Death and c‐fos [letter]. Nature 366: 308, 1993
13. 13 Fesus L, Thomazy V, Falus A: Induction and activation of tissue transglutaminase during programmed cell death. FEBS Lett 224: 104–108, 1987
14. 14 Giguère V, Ong ES, Segui P, Evans RM: Identification of a receptor for the morphogen retinoic acid. Nature 330: 624–629, 1987
15. 15 Gossler A, Joyner A, Rossant J, Skarnes WC: Mouse embryonic stem cells and reporter constructs to detect developmentally regulated genes. Science 244: 463–465, 1989
16. 16 Grigoriadis AE, Petkovich PM, Rosenthal EE, Heersche JNM: Modulation by retinoic acid of 1,25‐dihydroxyvitamin D 3 effects on alkaline phosphatase activity and parathyroid hormone responsiveness in an osteoblast‐like osteosarcoma cell line. Endocrinology 119: 932–939, 1986
17. 17 Herring SW, Muhl ZF, Obrez A: Bone growth and periosteal migration control masseter muscle orientation in pigs (Sus scrofa). Anat Rec 235: 215–222, 1993
18. 18 Husmann M, Lehmann J, Hoffmann B, Hermann T, Tzukerman M, Pfahl M: Antagonism between retinoic acid receptors. Mol Cell Biol 11: 4097–4103, 1991
19. 19 Iwamoto M, Golden EB, Adams SL, Noji S, Pacifici M: Responsiveness to retinoic acid changes during chondrocyte maturation. Exp Cell Res 205: 213–224, 1993
20. 20 Iwamoto M, Shapiro IM, Yagami K, Boskey AL, Leboy PS, Adams SL, Pacifici M: Retinoic acid induces rapid mineralization and expression of mineralization‐related genes in chondrocytes. Exp Cell Res 207: 413–420, 1993
21. 21 Jiang H, Kochhar DM: Induction of tissue transglutaminase and apoptosis by retinoic acid in the limb bud. Teratology 46: 333–340, 1992
22. 22 Kastner P, Krust A, Mendelsohn C, Garnier JM, Zelent A, Leroy P, Staub A, Chambon A: Murine isoforms of retinoic acid receptor gamma with specific patterns of expression. Proc Natl Acad Sci U S A 87: 2700–2704, 1990
23. 23 Kessel M, Gruss P: Homeotic transformations of murine vertebrae and concomitant alteration of Hox codes induced by retinoic acid. Cell 67: 89–104, 1991
24. 24 Kilcoyne RF, Cope R, Cunningham W, Nardella FA, Denman S, Franz TJ, Hanifin J: Minimal spinal hyperostosis with lowdose isotretinoin therapy. Invest Radiol 21: 41–44, 1986
25. 25 Kindmark A, Törmä H, Johansson AG, Ljunghall S, Melhus H: Cellular retinoic acid‐binding protein type II is expressed in adult human osteoblasts and in adult liver. Biochem Biophys Res Commun 189: 1397–1403, 1992
26. 26 Kindmark A, Törmäd H, Johansson A, Ljunghall S, Melhus H: Reverse transcription‐polymerase chain reaction assay demonstrates that the 9‐cis retinoic acid receptor‐α is expressed in human osteoblasts. Biochem Biophys Res Commun 192: 1367–1372, 1993
27. 27 Kochhar DM: Limb development in mouse embryos. I. Analysis of teratogenic effects of retinoic acid. Teratology 7: 289–298, 1973
28. 28 Lanske B, Karaplis AC, Lee K, Luz A, Vortkamp A, Pirro A, Karperien M, Defize LHK, Ho C, Mulligan RC, Abou‐Samra A‐B, Jüppner H, Segre GV, Kronenberg HM: PTH/PTHrP receptor in early development and Indian hedgehog‐regulated bone growth. Science 273: 663–666, 1996
29. 29 Leid M, Kutner P, Lyons R, Nakshatri H, Saunders M, Zacharewski T, Chen J‐Y, Staub A, Garnier JM, Mader S, Chambon P: Purification, cloning, and RXR identity of the HeLa cell factor with which RAR or TR heterodimerizes to bind target sequences efficiently. Cell 68: 377–395, 1992
30. 30 Macias D, Gañan Y, Hurlé JM: Modification of the phalangeal pattern of the digits in the chick embryo leg bud by local microinjection of RA, staurosporin and TGF β's. Anat Embryol 188: 201–208, 1993
31. 31 Mangelsdorf DJ, Ong ES, Dyck JA, Evans RM: A nuclear receptor that identifies a novel retinoic acid response pathway. Nature 345: 224–229, 1990
32. 32 Melnick B, Gluck S, Jungblut RM, Goerz G: Retrospective radiographic survey of skeletal changes after long‐term etretinate therapy. Br J Dermatol 116: 207–212, 1987
33. 33 Mendelsohn C, Ruberte E, LeMeur M, Morriss‐Kay G, Chambon P: Developmental analysis of the retinoic acid‐inducible RAR‐β 2 promoter in transgenic animals. Development 113: 723–734, 1991
34. 34 Nagy L, Saydak M, Shipley N, Lu S, Basilion JP, Yan ZH, Syka P, Chandraratna RA, Stein JP, Heyman RA, Davies PJ: Identification and characterization of a versatile retinoid response element (retinoic acid receptor response element‐retinoid X receptor response element) in the mouse tissue transglutaminase gene promoter. J Biol Chem 271: 4355–4365, 1996
35. 35 Nakayama Y, Takahashi K, Noji S, Muto K, Nishijima K, Taniguchi S: Functional modes of retinoic acid in mouse osteoblastic clone MC3T3‐E1, proved as a target cell for retinoic acid. FEBS Lett 261: 93–96, 1990
36. 36 Noji S, Yamasi T, Koyama E, Nohno T, Taniguchi S: Spatial and temporal expression pattern of retinoic acid receptor genes during mouse bone development. FEBS Lett 257: 93–96, 1989
37. 37 Oliva A, Della Ragione F, Fratta M, Marrone G, Palumbo R, Zappia V: Effect of retinoic acid on osteocalcin gene expression in human osteoblasts. Biochem Biophys Res Commun 191: 908–914, 1993
38. 38 Oreffo ROC, Teti A, Triffitt JT, Francis MJO, Carano A, Zallone AZ: Effect of vitamin A on bone resorption: evidence for direct stimulation of isolated Chicken osteoclasts by retinol and retinoic acid. J Bone Miner Res 3: 203–210, 1988
39. 39 Paige DC, Judge MR, Shaw DG, Atherton DJ, Harper JI: Bone changes and their significance in children with ichthyosis on longterm etretinate therapy. Br J Dermatol 127: 387–391, 1992
40. 40 Petkovich M, Brand NJ, Krust A. Chambon P: A human retinoic acid receptor which belongs to the family of nuclear receptors. Nature 330: 444–450, 1987
41. 41 Piacentini M, Fesus L, Farrace MG, Ghibelli L, Pirredda L, Melino G: The expression of “tissue” transglutaminase in two human cancer cell lines is related with the programmed cell death (apoptosis). Eur J Cell Biol 54: 246–254, 1991
42. 42 Piacentini M, Annicchiarico‐Petruzzelli M, Oliverio S, Piredda L, Biedler JL, Melino G: Phenotype‐specific tissue transglutaminase regulation in human neuroblastoma cells in response to retinoic acid: correlation with cell death by apoptosis. Int J Cancer 52: 271–278, 1992
43. 43 Pittsley RA, Yoder FW: Retinoid hyperostosis: skeletal toxicity associated with long‐term administration of 13‐cis‐retinoic acid for refractory ichthyosis. New Engl J Med 308: 1012–1014, 1983
44. 44 Raisz LG: Inhibition by actinomycin D of bone resorption induced by parathyroid hormone or vitamin A. Proc Soc Exp Biol Med 119: 614–617, 1965
45. 45 Reynolds JJ: Inhibition by calcitonin of bone resorption induced in vitro by vitamin A. Proc R Soc Lond [Biol] 170: 61–69, 1968
46. 46 Rossant J, Zirngibl R, Cado D, Shago M, Giguére V: Expression of a retinoic acid response element‐hsplacZ transgene defines specific domains of transcriptional activity during mouse embryogenesis. Genes Dev 5: 1333–1344, 1991
47. 47 Rowe A, Eager NSC, Brickell PM: A member of the RXR nuclear receptor family is expressed in neural‐crest‐derived cells of the developing chick peripheral nervous system. Development 111: 771–778, 1991
48. 48 Roy B, Taneja R, Chambon P: Synergistic activation of retinoic acid (RA)‐responsive genes and induction of embryonal carcinoma cell differentiation by an RA receptor alpha (RAR alpha)‐, RAR beta‐, or RAR gamma‐selective ligand in combination with a retinoid X receptor‐specific ligand. Mol Cell Biol 15: 6481–6487, 1995
49. 49 Ruberte E, Dollé P, Krust A, Zelent A, Morriss‐Kay G, Chambon P: Specific spatial and temporal distribution of retinoic acid receptor γ transcripts during mouse embryogenesis. Development 108: 213–222, 1990
50. 50 Ruberte E, Dollé P, Chambon P, Morriss‐Kay G: Retinoic acid receptors and cellular retinoid binding proteins. 2. Their differential pattern of transcription during early morphogenesis in mouse embryos. Development 111: 45–60, 1991
51. 51 Schule R, Rangarajan P, Yang N, Kliewer S, Ransone LJ, Bolado J, Verma IM, Evans RM: Retinoic acid is a negative regulator of AP‐1‐responsive genes. Proc Nat Acad Sci U S A 88: 6092–6096, 1991
52. 52 Shenefelt RE: Morphogenesis of malformations in hamsters caused by retinoic acid: relation to dose and stage at treatment. Teratology 5: 103–118, 1972
53. 53 Smeyne RJ, Vendrell M, Hayward M, Baker SJ, Miao GG, Schilling K, Robertson LM, Curran T, Morgan JI: Continous c‐fos expression precedes programmed cell death in vivo. Nature 363: 166–169, 1993
54. 54 Storm EE, Huynh TV, Copeland NG, Jenkins NA, Kingsley DM, Lee SJ: Limb alterations in brachypodism mice due to mutations in a new member of the TGF‐beta superfamidy. Nature 368: 639–643, 1994
55. 55 Sucov HM, Murakami KK, Evans RM: Characterization of an autoregulated response element in the mouseretionoic of an receptor type β gene. Proc Natl Acad Sci U S A 87: 5392–5396, 1990
56. 56 Sulik KK, Dehart DB: Retinoic‐acid‐induced limb malformations resulting from apical ectodermal ridge cell death. Teratology 37: 527–537, 1988
57. 57 Tabin CJ: Retinoids, homeoboxes, and growth factors: toward molecular models for limb development. Cell 66: 199–217, 1991
58. 58 Taneja R, Roy B, Plassat JL, Zusi CF, Ostrowski J, Reczek PR, Chambon P: Cell‐type and promoter‐context dependent retinoic acid receptor (RAR) redundancies for RAR beta 2 and Hoxa‐1 activation in F9 and P19 cells can be artefactually generated by gene knockouts. Proc Natl Acad Sci U S A 93: 6197–6202, 1996
59. 59 Tangrea JA, Kilcoyne RF, Taylor PR, Helsel WE, Adrianza ME, Hartman AM, Edwards BK, Peck GL: Skeletal hyperostosis in patients receiving chronic, very‐low‐dose isotretinoin. Arch Dermatol 128: 921–925, 1992
60. 60 Taniguchi Y, Tanaka T, Gotoh K, Satoh R, Inazu M: Transforming growth factor β1‐induced cellular heterogeneity in the periosteum of rat parieial bones. Calcif Tissue Int 53: 122–126, 1993
61. 61 Thaller C, Eichele G: Identification and spatial distribution of retinoids in the developing chick limb buds. Nature 327: 625–628, 1987
62. 62 von Schroeder HP, Hashimoto Y, Heersche JNM: The effects of natural and synthetic retinoids on the differentiation of RCJ C5.18 chondrogenic cells. Teratology 50: 54–62, 1994
63. 63 Vortkamp A, Lee K, Lanske B, Segre GV, Kronenberg HM, Tabin CJ: Regulation of rate of cartilage differentiation by Indian hedgehog and PTH‐related protein. Science 273: 613–622, 1996
64. 64 Williams GR, Bland R, Sheppard MC: Characterization of thyroid hormone (T3) receptors in three osteosarcoma cell lines of distinct osteoblast phenotype: interactions among T3, vitamin D3, and retinoid signaling. Endocrinology 135: 2375–2385, 1994
65. 65 Wobach SB: Vitamin‐A deficiency and excess in relation to skeletal growth. J Bone Joint Surg 29: 171–192, 1947
66. 66 Yu VC, Delsert C, Andersen B, Holloway JM, Devary OV, Näär AM, Kim SY, Boutin JM, Glass CK, Rosenfeld MG: RXRβ: a coregulator that enhances binding of retinoic acid, thyroid hormone, and vitamin D receptors to their cognate response elements. Cell 67: 1251–1266, 1991
67. 67 Zelent A, Krust A, Petkovich M, Kastner P, Chambon P: Cloning of murine α and β retinoic acid receptors and a novel receptor predominantly expressed in skin. Nature 339: 714–717, 1989
68. 68 Zimmermann B, Tsambaos D: Retinoids inhibit the differentiation of embryonic‐mouse mesenchymal cells in vitro. Arch Dermatol Res 277: 98–104, 1985
69. 69 Zou H Niswander L: Requirement for BMP signaling in interdigital apoptosis and scale formation. Science 272: 738–741, 1996